TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
SNWV

SANUWAVE Health, Inc.

Healthcare · Medical Devices

5.90$ +1.4% vs. previous close Closing price · As of: Nov 3, 2026

Investor relations

Report Dates

Investor relations overview for SANUWAVE Health, Inc. (SNWV): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/06/2026.

Next report 11/06/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q2 25 · 111.1 % 25 Q3 25 · 43.8 % 25 Q4 25 · -82.4 % 25 Q1 26 · -19.6 % 26 Q2 26 · -166.7 % 26

EPS estimate beaten

Full history 20 of 51 quarters (39%)
Last 16 quarters 3 of 16 quarters (19%)

Earnings Call Transcripts

Search all transcripts →

  • 08/07/2026 Earnings Call Q2 2026 Open →
  • 05/13/2026 Earnings Call Q1 2026 Open →
  • 03/27/2026 Earnings Call Q4 2025 Open →
  • 10/06/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →
  • 05/09/2025 Earnings Call Q1 2025 Open →
  • 03/21/2025 Earnings Call Q4 2024 Open →
  • 11/08/2024 Earnings Call Q3 2024 Open →
  • 08/13/2024 Earnings Call Q2 2024 Open →
  • 05/10/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 10/28/2026 SANUWAVE Health, Inc. (SNWV): Entry into a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗
  • 09/25/2026 SANUWAVE Health, Inc. (SNWV): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · sec.gov Open ↗
  • 08/06/2026 SANUWAVE Health, Inc. (SNWV): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/13/2026 SANUWAVE Health, Inc. (SNWV): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?